Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4dac022280ec96f54c694eb427655932 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04 |
filingDate |
2003-06-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0188fa395ba3d42eb6f3e13b24b1bb12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3a47c84dd24a3b6ac58e5c33f3609504 |
publicationDate |
2004-03-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2004005287-A9 |
titleOfInvention |
Pyrazoloisoquinoline derivatives for inhibiting nfkappab-inducing kinase (nik) |
abstract |
The invention relates to compounds of formula (I), which are suitable for producing medicaments for the prophylaxis and treatment of diseases, the progression of which involves an increased activity of NIK. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2315751-A1 |
priorityDate |
2002-07-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |